Tackling Acute Gastroenteritis: RedHill Biopharma's Bekinda A Novel Approach?

A new long-acting ondansetron product that reduces nausea and vomiting during acute viral gastroenteritis, whatever the type of virus involved and for long periods of time, could change the way emergency physicians respond to gastroenteritis outbreaks, and is underpinning the specialty pharma business strategy of RedHill Biopharma.

Gastroenteritis
• Source: Shutterstock

More from Clinical Trials

More from R&D